
Sign up to save your podcasts
Or


In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s ruling to uphold the Affordable Care Act (ACA) (00:35), the announcement of additional mandatory payment models from the Center for Medicare & Medicaid Innovation (CMMI) (04:20), America’s Health Insurance Plans rebranding as “AHIP” (08:13), the Institute of Clinical and Economic Review’s (ICER) decision to investigate the impact of health plan policies on prescription drug costs (11:18), and finally, the FDA approval of Biogen’s Alzheimer’s therapy (15:15).
Podcast Tags: ACA, CMMI, value based care, AHIP, health insurance, ICER, drug prices, Alzheimer’s, healthcare, healthcare news
Source Links:
· https://www.healthcaredive.com/news/supreme-court-upholds-aca-in-7-2-decision-leaving-intact-landmark-us-healt/599060/
· https://www.healthcaredive.com/news/cmmis-fowler-more-mandatory-payment-models-likely/601258/
· https://www.fiercehealthcare.com/payer/ahip-launching-first-rebranding-effort-nearly-2-decades
· https://www.biopharmadive.com/news/icer-insurers-scrutiny-drug-plan-design/600767/
· https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Healthcare Industry Strategist
By Inizio Ignite4.9
3434 ratings
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s ruling to uphold the Affordable Care Act (ACA) (00:35), the announcement of additional mandatory payment models from the Center for Medicare & Medicaid Innovation (CMMI) (04:20), America’s Health Insurance Plans rebranding as “AHIP” (08:13), the Institute of Clinical and Economic Review’s (ICER) decision to investigate the impact of health plan policies on prescription drug costs (11:18), and finally, the FDA approval of Biogen’s Alzheimer’s therapy (15:15).
Podcast Tags: ACA, CMMI, value based care, AHIP, health insurance, ICER, drug prices, Alzheimer’s, healthcare, healthcare news
Source Links:
· https://www.healthcaredive.com/news/supreme-court-upholds-aca-in-7-2-decision-leaving-intact-landmark-us-healt/599060/
· https://www.healthcaredive.com/news/cmmis-fowler-more-mandatory-payment-models-likely/601258/
· https://www.fiercehealthcare.com/payer/ahip-launching-first-rebranding-effort-nearly-2-decades
· https://www.biopharmadive.com/news/icer-insurers-scrutiny-drug-plan-design/600767/
· https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Learning Lead
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Healthcare Industry Strategist